Loading...
We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord
- Ticker
- ALCOR.PA
- Price
- -
- Stock movement up
- +- (%)
- Company name
- Biocorp Production SA
- Exchange
- (PA ,
- Currency
- EUR )
- Sector
- Healthcare >Medical Devices
- Market cap
- 154.53M
- Ent value
- 161.98M
- Price/Sales
- 7.06
- Price/Book
- 62.80
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- -
- Forward P/E
- 97.50
- PEG
- -
- EPS growth
- -41.79%
- 1 year return
- 134.00%
- 3 year return
- 7.19%
- 5 year return
- 34.48%
- 10 year return
- -
Last updated: 2024-12-17
DIVIDENDS
ALCOR.PA does not pay dividends or no data was received
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | - |
| Price to OCF | - |
| Price to FCF | - |
| Price to EBITDA | - |
| EV to EBITDA | - |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | 7.06 |
| Price to Book | 62.80 |
| EV to Sales | 7.40 |
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 4.40M |
| EPS (TTM) | -0.08 |
| FCF per share (TTM) | -0.47 |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 21.90M |
| Gross profit (TTM) | 20.45M |
| Operating income (TTM) | -667.17K |
| Net income (TTM) | -356.94K |
| EPS (TTM) | -0.08 |
| EPS (1y forward) | 0.36 |
Margins
Loading...
Margins data
| Gross margin (TTM) | 93.38% |
| Operating margin (TTM) | -3.05% |
| Profit margin (TTM) | -1.63% |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 2.67M |
| Net receivables | 3.56M |
| Total current assets | 8.61M |
| Goodwill | 21.00K |
| Intangible assets | 19.13K |
| Property, plant and equipment | 0.00 |
| Total assets | 12.58M |
| Accounts payable | 1.16M |
| Short/Current long term debt | 5.78M |
| Total current liabilities | 2.69M |
| Total liabilities | 10.12M |
| Shareholder's equity | 2.46M |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | -166.84K |
| Capital expenditures (TTM) | 1.91M |
| Free cash flow (TTM) | -2.07M |
| Dividends paid (TTM) | 0.00 |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | -14.51% |
| Return on Assets | -2.84% |
| Return on Invested Capital | -4.33% |
| Cash Return on Invested Capital | -25.17% |
STOCK INFORMATION
Downside potential
Loading...
Downside potential data
| ALCOR.PA | S&P500 | |
| Current price drop from All-time high | -9.30% | -8.66% |
| Highest price drop | -64.86% | -56.47% |
| Date of highest drop | 5 Oct 2022 | 9 Mar 2009 |
| Avg drop from high | -30.35% | -11.07% |
| Avg time to new high | 57 days | 12 days |
| Max time to new high | 1204 days | 1805 days |
COMPANY DETAILS
Marketcap
154.53M
Marketcap category
Small-cap
Description
Biocorp Production designs, develops, and manufactures medical devices in France. The company provides Inspair, a smart cap to monitor inhalers and assesses the usage of the device; Mallya, a smart cap for pen injectors that captures injection data; Datapen, a motor driven pen injector; and Injay which collects essential information, such as injection completed, time and date, type of drug, batch number, and expiration date. It also offers pharmaceutical devices, such as NEWGUARD, a safety device compatible with various sizes of prefilled syringes; BIOPASS, a reconstitution system with a needle; Sween, a device that provides real assistance in the administration of medication and closure systems. The company was incorporated in 2004 and is headquartered in Issoire, France. As of August 4, 2023, Biocorp Production operates as a subsidiary of Novo Nordisk A/S.
Employees
85
Website
Investor relations
-
SEC filings
CEO
Country
France
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
All newsPress releases
No items found